Description
Restiro 100mg tablets contain Resmetirom, a thyroid hormone receptor-beta (THR-β) agonist,
designed to treat adult patients with noncirrhotic nonalcoholic Restiro 100 mg tablet online steatohepatitis (NASH) accompanied by.
moderate-to-advanced liver fibrosis. It works by reducing Restiro 100 mg tablet price intrahepatic triglycerides.
and is used as an adjunct to diet and Restiro 100 mg tablet in Pakistan exercise.
Primary Indication: Patients with NASH/MASH accompanied by fibrosis stages F2 to F3 of the liver.
Mode of action: Binds selectively THR -β in the liver; causes fat decomposition; reverses fat overload.
Recommended Dosage: Given orally in one daily dose. The dose may be different depending on the weight of the patient (prescribed for people with the mass exceeding 100 kg) and functioning of the liver.
Significant Warning: The drug should be taken strictly under specialised medical supervision, e.g. herpetologist’s guidance as suggested by Mr Medicine Mart.
Adverse Effects and Precautions Common adverse effects: Diarrhea, nausea, itching, abdominal pain, vomiting, dizziness, and constipation.Potential adverse effects: Risk of developing hepa totoxicity and other complications related to the functioning of gallbladder (e.g., development of gallstones).Drug Interactions: Causes increased levels of ator vastatin, rosuvastatin, and other statins; thus, doses of these drugs need adjustment.
Resmetirom (under trade name Rezdiffra) is an oral medicine that should be taken once a day to treat adults with metabolic dysfunction-associated steato hepatitis (MASH) also referred to previously as nonalcoholic steatohepatitis (NASH). The treatment concerns patients with moderately to severely scarred liver, without the development of cirrhosis.
Resmetirom is used along with proper diet and exercise to treat metabolic dysfunction-associated steato hepatitis (MASH) in adults.
